Urethral strictures refer to the narrowing of the urethra, which is the tube that carries urine out of the body. This condition is typically caused by scarring, which can block or narrow the urethra, ...
Synchronous metastatic disease is characterized by the presence of metastatic lesions, in addition to the primary tumor, at diagnosis. Investigators in South Korea demonstrated the benefit in a ...
The Optilume device includes a balloon coated with paclitaxel. The Food and Drug Administration (FDA) has approved the Optilume ® Urethral Drug Coated Balloon (DCB) to treat patients with obstructive ...
The FDA has granted approval to Urotronic Inc. for its Optilume urethral drug-coated balloon (DCB) for the treatment of male urethral strictures. The device inhibits new scar tissue growth that may ...
TOKYO--(BUSINESS WIRE)--Treating male urethral stricture with the patient’s own buccal mucosal cells, encapsulated in a polymer scaffold as carrier, has been granted a patent in Japan. A longer ...
Source: Getty Images In a cohort study, 7% of patients had life-threatening complications associated with urethral stricture. Certain patients have an increased risk for complications from urethral ...
Edogawa Hospital plans urethral reconstruction center, setting up Boron Neutron Capture Therapy (BNCT) for Cancer treatment. TOKYO--(BUSINESS WIRE)--Urethral stricture, blocking the passage of urine ...
Optilume is a urethral balloon coated with paclitaxel (3.5 microgram/mm 2). It is indicated for managing urethral stricture disease in 'adult males'. It is designed to be used as a drug-coated ...
Treating male urethral stricture with the patient’s own buccal mucosal cells, encapsulated in a polymer scaffold as carrier, has been granted a patent in Japan. A longer duration of relief to patients ...
Posterior urethral disruption is a traumatic injury to the male urethra, which most often results from pelvic fracture. After trauma, the distraction defect between the two ends of the urethra often ...
The FDA has granted approval to Urotronic Inc. for its Optilume urethral drug-coated balloon (DCB) for the treatment of male urethral strictures. The device inhibits new scar tissue growth that may ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results